Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1

NCT02605265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

356

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

RADIATION: Radiation
DRUG: Capecitabine
DRUG: Irinotecan
DRUG: Oxaliplatin

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]